|
Choose Maryland > About Us

Maryland Venture Fund Authority The mission of the nine-member Maryland Venture Fund Authority is to oversee implementation of InvestMaryland, a public-private partnership to spur venture capital investment and fuel Maryland’s innovation economy.
 
 |
|
Chairman
Since joining MedImmune in 2006 as Senior Vice President, Commercial Operations, Peter Greenleaf has overseen the development of the company's global marketing and portfolio organizations, as well as managing the broader commercial, corporate development and strategy functions. Greenleaf manages a portfolio of 140+ assets across all phases of development in five core therapeutic areas.
|
|
|

|
Gina Dubbe |
Managing Partner & Co- Founder, Walker Ventures |
|
Michael J. Howard |
Chairman & Managing Member, MJH Group, LLC |
| Andrew Jones |
Vice President of Corporate Strategy, High Street Partners |
|
Elizabeth Good Mazhari |
Director of Ventures, Johns Hopkins University School of Medicine |
| S. Tien Wong |
Chairman & CEO, Lore Systems, Inc. |
|
Goodloe E. Byron Jr. |
Founder & President, Potomac Investment Services |
|
Brian Darmody |
Associate VP of Research & Economic Development, University of Maryland |
| Michael G. Miller |
Principal, The Arundel Group |
|
|
|
|

 Michelle D. Jackson Director, Boards and Commissions 410.767.6881
Maryland Venture Fund Authority 401 E. Pratt St, 7th floor Baltimore, MD 21202
|